{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+equivalent&page=27", "query": { "intervention": "Placebo equivalent", "page": 27 }, "page_size": 10 }, "pagination": { "page": 27, "page_size": 10, "total_count": 843, "total_pages": 85, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+equivalent&page=28&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+equivalent&page=26&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T01:43:12.051Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02759185", "title": "Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Posttraumatic Stress Disorder" ], "interventions": [ { "name": "High THC cannabis", "type": "DRUG" }, { "name": "High CBD cannabis", "type": "DRUG" }, { "name": "THC/CBD cannabis", "type": "DRUG" }, { "name": "Placebo cannabis", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Multidisciplinary Association for Psychedelic Studies", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2017-01-02", "completion_date": "2019-01", "has_results": true, "last_update_posted_date": "2023-07-12", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02759185" }, { "nct_id": "NCT00333398", "title": "Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free", "type": "BIOLOGICAL" }, { "name": "CSL Trivalent Inactivated Influenza Vaccine with Thimerosal", "type": "BIOLOGICAL" }, { "name": "Placebo with Thimerosal", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 1359, "start_date": "2006-06", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2010-08-27", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 10, "location_summary": "Stanford, California • Iowa City, Iowa • Baltimore, Maryland + 7 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00333398" }, { "nct_id": "NCT04435626", "title": "Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Finerenone (BAY94-8862)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 6016, "start_date": "2020-09-14", "completion_date": "2024-06-14", "has_results": true, "last_update_posted_date": "2025-08-26", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 107, "location_summary": "Birmingham, Alabama • Fairhope, Alabama • Mobile, Alabama + 98 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04435626" }, { "nct_id": "NCT02855450", "title": "Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "rhNGF", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dompé Farmaceutici S.p.A", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 60, "start_date": "2016-12", "completion_date": "2018-05", "has_results": true, "last_update_posted_date": "2020-11-25", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02855450" }, { "nct_id": "NCT02204813", "title": "To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bypass, Gastric", "Roux-en-Y Gastric Bypass", "Vertical Sleeve Gastrectomy", "Gastric Banding", "Bariatric Surgery" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Lo-Xenin", "type": "DRUG" }, { "name": "Hi-Xenin", "type": "DRUG" }, { "name": "Extra Hi-Xenin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2014-07", "completion_date": "2015-11-17", "has_results": false, "last_update_posted_date": "2018-04-27", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02204813" }, { "nct_id": "NCT02527798", "title": "Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bronchopulmonary Dysplasia" ], "interventions": [ { "name": "Furosemide Cohort 1", "type": "DRUG" }, { "name": "Furosemide Cohort 2", "type": "DRUG" }, { "name": "Furosemide Cohort 3", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "28 Days", "sex": "ALL", "summary": "7 Days to 28 Days" }, "enrollment_count": 82, "start_date": "2015-11-27", "completion_date": "2019-10-15", "has_results": true, "last_update_posted_date": "2021-12-28", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • Loma Linda, California • Jacksonville, Florida + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Loma Linda", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02527798" }, { "nct_id": "NCT00269048", "title": "SB-480848 In Subjects With Coronary Heart Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "SB-480848", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 969, "start_date": "2005-11", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2016-08-08", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Northport, Alabama • Phoenix, Arizona + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Spring Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00269048" }, { "nct_id": "NCT04759833", "title": "A Study of Prucalopride For Functional Constipation in Children and Teenagers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Constipation" ], "interventions": [ { "name": "Prucalopride", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Months to 17 Years" }, "enrollment_count": 175, "start_date": "2021-07-13", "completion_date": "2023-11-13", "has_results": true, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Anaheim, California + 32 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04759833" }, { "nct_id": "NCT02177513", "title": "Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cannabis Use" ], "interventions": [ { "name": "Placebo + Placebo", "type": "DRUG" }, { "name": "Oral Cannabis + Placebo", "type": "DRUG" }, { "name": "Placebo + Inhaled Cannabis", "type": "DRUG" }, { "name": "Placebo + Smoked Cannabis", "type": "DRUG" }, { "name": "6.9% cannabis oral", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Drug Abuse (NIDA)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 28, "start_date": "2014-06-14", "completion_date": "2016-04-27", "has_results": false, "last_update_posted_date": "2019-12-16", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02177513" }, { "nct_id": "NCT01954082", "title": "Inositol to Reduce Retinopathy of Prematurity", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Retinopathy of Prematurity (ROP)" ], "interventions": [ { "name": "myo-Inositol 5% Injection", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NICHD Neonatal Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Hours", "maximum_age": "72 Hours", "sex": "ALL", "summary": "12 Hours to 72 Hours" }, "enrollment_count": 638, "start_date": "2014-04-17", "completion_date": "2016-12-31", "has_results": true, "last_update_posted_date": "2019-03-22", "last_synced_at": "2026-11-15T01:43:12.051Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01954082" } ] }